Prospactive study for Cyclophosphamide-induced cardiomyopathy

Prospactive study for Cyclophosphamide-induced cardiomyopathy - Cyclophosphamide, prospective studdy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019543

Enrollment

Registered

2015-10-28

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cyclophosphamide-induced cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who used cyclophosphamide more than 100mg/kg

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Incidence of cyclophosphamide-induced cardiomyopathy	—

Countries

Japan

Contacts

Public ContactKeiji Noguchi

Hokkaido University Graduate School of Medicine Department of Cardiovascular Medicine

fs_at@mac.com011-706-6973

Outcome results